Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.

This study is not yet recruiting. It focuses on bipolarity and currently lists study information in China.
Leave your email and HopeStage can help you better understand this study.
This study is looking at whether Colorectal ESD with SpydrBlade Flex can help people with Colon Polyp or Colon Neoplasia. Participants take part in Colorectal ESD with SpydrBlade Flex and complete follow-up assessments. Taking part may give some people access to Colorectal ESD with SpydrBlade Flex, but direct benefit is not guaranteed.
The official record suggests in-person participation through a university, with sites including The Chinese University of Hong Kong. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually being able to understand the study and consent and meeting the main study requirements, while common reasons not to take part include pregnancy or breastfeeding and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it adds public evidence around bipolarity. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in China.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Chinese University of Hong Kong. Based on the sponsor name or official registry information, it appears to be a university. You should verify the details in the official registry record.
This study may involve medication or study treatment, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me